Since M-EPCs secrete high levels of CCL3 compared with significantly low levels by F-EPCs and OVX-EPCs, we evaluated the expression of CCL3 in post-MI hearts of the different treatment groups. This evidence concerns the gene CCL3 and myocardial infarction.